Organic anion (OA) transport mediates accumulation of the zwitterionic nephrotoxic cysteine S-conjugates S-dichlorovinylcysteine (DCVC) and S-chlorotrifluoroethylcysteine (CTFC) in the rabbit renal proximal tubule (RPT). Although these cysteine conjugates are nephrotoxic to the human RPT, neither the role of OA transport nor the specific OA transport pathway(s) involved in cysteine conjugate accumulation are known. Since the OAT1 transporter has the characteristics of para-aminokippurate (PAH) transport that closely correlate to the native RPT, we examined the interaction of DCVC, CTFC, and the nontoxic benzothiazolylcysteine (BTC) with PAH transport mediated by human OAT1 and rabbit Oat1 expressed in Chinese hamster ovary and COS7 heterologous expression systems, respectively. Although the K m values for PAH uptake by hOAT1 and rbOat1 (8.9 Ϯ 3.6 and 20.7 Ϯ 8 M, respectively) were 5-to 10-fold less than the K m for peritubular PAH transport into rabbit RPT, the IC 50 values for DCVC, CTFC, and BTC inhibition of PAH uptake mediated by either hOAT1 or rbOat1 were similar between these two transporters and to the IC 50 values for these conjugates measured in rabbit RPT. The IC 50 for inhibition of hOAT1-and rbOat1-mediated PAH uptake by the hydrophobic conjugate BTC was more than 5-fold lower than the IC 50 values seen with DCVC and CTFC, suggesting that hydrophobicity increases the affinity of OAT1 for cysteine conjugates. Finally, preloading cells transfected with hOAT1 with BTC significantly trans-stimulated the uptake of PAH, consistent with the conclusion that BTC and, hence, other cysteine S-conjugates are substrates for hOAT1.
One mechanism to protect the body from exposure to potentially toxic "xenobiotics" is the removal of these typically "organic" and often "anionic" substances from the systemic circulation and their excretion into the urine by the renal organic anion secretory pathway. Organic anion (OA) secretion is a two-step process involving a basolateral membrane carrier that moves a negatively charged organic molecule from the blood into the renal proximal tubule (RPT) cell in conjunction with an apical membrane carrier that moves the substrate from the cell into the tubular lumen. The basolateral step involves the uphill transport of an OA into the cell in exchange for intracellular dicarboxylate (Pritchard and Miller, 1996) . Although OA transporters OAT1, OAT2, OAT3, and OAT4 have been cloned, OAT1 displays the characteristics of ␣-ketoglutarate/OA exchange and a broad substrate specificity associated with native RPT basolateral membrane OA transport (Ullrich, 1997; Sekine et al., 1998; Hosoyamada et al., 1999; Kusuhara et al., 1999; Lu et al., 1999; Cha et al., 2000) . OAT1 mediates PAH transport and has been cloned from the rat, mouse, flounder, human, and rabbit (Sekine et al., 1997; Sweet et al., 1997; Wolff et al., 1997; Reid et al., 1998; Hosoyamada et al., 1999; Kogo et al., 1999; Bahn et al., 2002) . Because OAT1 seems capable of transporting a wide array of structurally diverse substrates, the accumulation of toxic substrates within the renal cell by this pathway may be involved in xenobiotic toxicity.
Conjugation of xenobiotics with glutathione (GSH) increases their hydrophilicity, thereby enhancing their excretion, making conjugation an important detoxification mechanism. Conjugation of trichloroethylene and chlorotrifluoroethylene with GSH and the accumulation of GSH-conjugates or their metabolites are required to exert nephrotoxicity (Odum and Green, 1984) . Glutathione conjugates of trichloroethylene and chlorotrifluoroethylene, ultimately, are cleaved to form the zwitterionic cysteine conjugates S-dichlorovinylcysteine (DCVC) and S-chlorotrifluoroethylcysteine (CTFC). These cysteine conjugates are accumulated by the RPT and biotransformed by cysteine conjugate ␤-lyase to a reactive thiol resulting in RPT lesions (Odum and Green, 1984; Lock and Ishmael, 1985) . Many cysteine con-jugates, however, are detoxified by the addition of an N-acetyl, forming a negatively charged mercapturic acid (Stevens and Jones, 1989) that is accumulated by the RPT. The N-acetyl group can then be removed intracellularly by the enzyme deacetylase to reform the cysteine conjugate. Thus, accumulation of cysteine conjugates, such as DCVC and CTFC, and their N-acetyl cysteine conjugate derivatives by the RPT is paramount to the production of toxicity (Weinberg, 1993) .
Although many cysteine S-conjugates appear to be nephrotoxic and even nephrocarcinogenic in humans (Chen et al., 1990; Birner et al., 1993 Birner et al., , 1997 Bruning and Bolt, 2000; Lash et al., 2000) , the role of the human organic transporter 1 (hOAT1) in the transport of these substrates has been not shown. Although the negatively charged N-acetyl derivatives of DCVC (NAC-DCVC) and of CTFC (NAC-CTFC) have been shown to be substrates for rat Oat1 (Pombrio et al., 2001) , the interaction of the parent zwitterionic cysteine conjugate DCVC or CTFC with OAT1 is not known. Indeed, studies with rat renal slices and isolated renal membranes (Schaeffer and Stevens, 1987; Wolfgang et al., 1989) suggested that zwitterionic cysteine conjugates interact poorly with rat renal organic anion transport. Different results, however, have been observed with the rabbit kidney. Both DCVC and CTFC cis-inhibit and trans-stimulate basolateral membrane PAH and fluorescein transport in the rabbit RPT (Dantzler et al., 1995 (Dantzler et al., , 1998 Groves and Morales, 1999) , suggesting that these toxicants are substrates for the basolateral OA transport pathway (including and possibly dominated by OAT1) in the native RPT. In addition, high PAH concentrations prevent DCVC-induced losses of intracellular potassium from single S2 RPT segments from the rabbit kidney (Dantzler et al., 1998) , indicating that transport of this substrate via OAT1 may be involved in cysteine S-conjugate-mediated toxicity. Consequently, to further characterize and understand the molecular mechanisms of organic anion secretion in humans, the present article compared the interaction of nephrotoxic cysteine S-conjugates with hOAT1-mediated PAH transport to that observed with rbOat1. The results demonstrated that cysteine S-conjugate interaction is similar for both human and rabbit Oat1. The IC 50 values for inhibition of PAH uptake by DCVC, CTFC, and S-benzothiazolylcysteine (BTC) were similar to the affinities for inhibition of PAH transport previously measured for these substrates in isolated rabbit RPT. As previously reported, PAH is a high affinity substrate for hOAT1, and the affinity of rbOat1 for PAH is markedly higher than implied from studies using isolated rabbit RPT. The data from this study suggest that hOAT1 and rbOat1 share similar characteristics for PAH transport and substrate interaction.
Materials and Methods

Materials. [
3 H]PAH (specific activity, 4 Ci/mmol) was purchased from PerkinElmer Life Sciences (Boston, MA). DCVC and BTC were a gift from Dr. A. Jay Gandolfi (Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ). All other chemicals were purchased from standard sources and were of the highest purity available.
Stably and Transiently Transfected Cell Lines. CHO hOAT1 cells were generated by stable transfection of hOAT1 cDNA into Chinese hamster ovary cells, as described by Ho et al. (2000) , and were a generous gift from Dr. Thomas Cihlar (Gilead Sciences, Foster City, CA). The cells were maintained in a Ham's F-12 medium with a Kaighn's modification supplemented with 10% fetal bovine serum, 50 U/ml pen-strep, and 1 mg/ml G418. For studies with rbOat1, COS7 cells were grown in Ham's F-12 with a Kaighn's modification supplemented with 10% fetal bovine serum and 50 U/ml pen-strep. COS7 cells were transiently transfected with rbOat1 by electroporation using a modification of the protocol of Baum et al. (1994) . Briefly, COS7 cells were lifted from the culture flask by treatment with 0.25% trypsin/1 mM EDTA and resuspended at a concentration of 5 ϫ 10 6 cells/ml. An aliquot of 0.4 ml of cell suspension was transferred to a cuvette containing 10 g of rbOat1 cDNA and 10 g of salmon sperm DNA. Cells were electroporated using a BTX Electro-cell manipulator (BTX, San Diego, CA To stop transport at timed intervals from 0.25 to 10 min, medium was aspirated, and cells were rinsed three times in ice-cold 0.3 mM probenecid. Cells were dissolved in 1 N NaOH, and aliquots were taken for liquid scintillation counting. Uptakes were expressed per squared centimeter of nominal cell surface area of a confluent cell layer.
Measurement of trans-Stimulation of [ 3 H]PAH Uptake.
To determine the effect of efflux of unlabeled substrate on the uptake of [ 3 H]PAH (trans-stimulation), CHO cells and COS7 cells were incubated for 1 h in Waymouth's buffer in the absence of substrate or in the presence of 0.5 mM PAH or BTC. After 1 h, the cells were rinsed three times with room temperature Waymouth's, followed by the addition of 1 Ci/ml [ 3 H]PAH to measure uptake. To stop transport at various time intervals, medium was aspirated and the cells rinsed and dissolved as described above.
Results
Kinetics of [
3 H]PAH Uptake in CHO Cells Stably Transfected with hOAT1 and in COS7 Cells Transiently Transfected with rbOat1. The uptake of [ 3 H]PAH in hOAT1-expressing CHO cells and rbOat1-expressing COS7 cells increased with time ( Fig. 1 ) and was reduced approximately 90% at all time points by the addition of 1 mM unlabeled PAH (data not shown). Uptake into the CHO cells was 2-fold more rapid than uptake into COS7 cells, probably reflecting different levels of protein expression. Estimates of the initial rate of OAT1-mediated transport in subsequent experiments were based on 30-s uptakes in the CHO cells (Fig. 1A) and 2-min uptakes in the COS7 cells (Fig. 1B) .
To characterize the interaction of PAH with hOAT1, the kinetics of PAH uptake were examined in hOAT1 transfected CHO cells. As shown in Fig. 2A, increasing H]PAH by increasing concentrations of unlabeled PAH was adequately described by the kinetics of competitive inhibition using a modification of the isotope dilution procedure, as described by Malo and Berteloot (1991) .
where J is the rate of cellular PAH uptake from an extracellular concentration of [ 3 H]PAH of [T*] in the presence of an unlabeled PAH concentration of [S] . The kinetics parameters J max , K m , and C are defined as the maximal capacity of the carrier for PAH, the concentration of PAH at 1/2J max , and a coefficient describing the nonsaturable accumulation of PAH (passive diffusion and/or nonspecific binding). The J max and K m values generated from the analysis of the kinetics of hOAT1-mediated [ 3 H]PAH transport in three separate passages of stably transfected CHO cells were 3.8 Ϯ 0.9 pmol ⅐ cm Ϫ2 ⅐ min Ϫ1 and 8.9 Ϯ 3.6 M, respectively. As with hOAT1-mediated PAH uptake, increasing concentrations of unlabeled PAH progressively reduced the uptake of [ 3 H]PAH by rbOat1-transfected COS7 cells (Fig. 2B) . From three separate electroporated cell passages, the J max and K m values measured for PAH uptake by rbOat1 were 74.9 Ϯ 29 pmol ⅐ cm Ϫ2 ⅐ min Ϫ1 and 20.7 Ϯ 8 M, respectively. Kinetics of cis-Inhibition of PAH Uptake by Cysteine S-Conjugates in CHO Cells Stably Transfected with hOAT1 and in COS7 Cells Transiently Transfected with rbOat1. The nephrotoxic cysteine S-conjugates DCVC and CTFC and the nontoxic cysteine S-conjugate BTC have been shown to be substrates for an organic anion transport pathway in single rabbit RPT S2 segments and suspensions of rabbit RPT (Dantzler et al., 1995 (Dantzler et al., , 1998 Groves and Morales, 1999) . Since multiple organic anion pathways have been cloned from the RPT, the interaction of these substrates directly with the cloned hOAT1 and rbOat1 transporters was examined for comparison to data we previously generated with these substrates using rabbit RPT. Increasing concentrations of DCVC, CTFC, and BTC progressively reduced the uptake of [ 3 H]PAH in CHO cells stably transfected with hOAT1 ( Fig. 3) and in COS7 cells transiently transfected with rbOat1 (Fig. 4) . BTC produced the most effective inhibition of uptake, with IC 50 values (the concentration of inhibitor that reduced the uptake of radiolabeled substrate by 50%) for inhibition of PAH uptake of 9.9 Ϯ 2.5 M for hOAT1 and 14.9 Ϯ 3 M for rbOat1 ( (Table 1) . The apparent affinities of hOAT1 and rbOat1 for DCVC and CTFC did not differ substantially from the apparent K i values measured for inhibition of PAH transport by these substrates in the intact rabbit RPT, 86.4 Ϯ 7.6 and 105 Ϯ 3 M for DCVC and CTFC, respectively (Table 1) (Dantzler et al., 1995; Groves and Morales, 1999) . Interestingly, the IC 50 values for DCVC inhibition of PAH uptake by hOAT1 and rbOat1 (Table 1) were similar to the K m value of 283 Ϯ 23.3 M for DCVC transport in rabbit RPT S2 segments (Dantzler et al., 1998) , consistent with a role for OAT1 in cysteine S-conjugate uptake by the native RPT.
To determine whether the cysteine S-conjugates DCVC and CTFC reduced transport via a direct interaction with OAT1 or through causing cytotoxicity, CHO cells or COS7 cells were incubated for 2 to 3 min (the longest time points used to examine kinetics) with the highest concentration of these substrates (in the absence of [ ]PAH uptake by BTC, DCVC, and CTFC indicated an interaction between OAT1 and these cysteine S-conjugates but did not reveal whether the interaction is competitive. To determine the type of interaction between cysteine S-conjugates and transport of PAH, 30-s uptakes of [ 3 H]PAH into CHO hOAT1 cells were measured in the presence of increasing concentrations of unlabeled PAH; however, these measurements also were made in the presence of a single concentration (400 M) of DCVC that should increase the K m for PAH uptake at least 3-fold if the interaction is competitive. In four separate experiments, the presence of DCVC increased the K m for hOAT1-mediated PAH transport approximately 4-fold (from 3.3 Ϯ 1.7 to 13.6 Ϯ 5.8 M), with only a modest change in J max (from 1.2 Ϯ 0.3 to 2.0 Ϯ 0.6 mol ⅐ cm Ϫ2 ⅐ min Ϫ1 ), which is consistent with a competitive interaction of this toxicant with hOAT1.
trans-Stimulation of [ 3 H]PAH Uptake by Cysteine S-Conjugates in hOAT1 and rbOat1 Transfected Cells.
Both DCVC and CTFC have been shown to trans-stimulate the efflux of PAH and/or the OA fluorescein, consistent with the conclusion that these toxicants are substrates for a common OA transporter in the native RPT (Dantzler et al., 1995; Groves and Morales, 1999) . Due to the rapid uptake and efflux of [ 3 H]PAH typically displayed in the native RPT, the ability of these toxicants to trans-stimulate PAH efflux can Under these conditions (1-h preloading with 0.5 mM DCVC or CTFC), however, toxicity is a major concern. Consequently, our examination of trans-effects was limited to the influence of preloading cells for 1 h with the nontoxic cysteine S-conjugate BTC, which was then compared with that produced by preloading cells with unlabeled PAH. As shown in Fig. 5, hOAT1 -mediated uptake of [ 3 H]PAH increased approximately 33 and 47%, respectively, when CHO-hOAT1 cells were preloaded with 0.5 mM BTC or 0.5 mM PAH. These data support the conclusion that cysteine S-conjugates are transportable substrates of hOAT1.
Discussion
Glutathione conjugation of substrates is a mechanism employed by the body to make hydrophobic substances more water soluble, thereby facilitating their excretion. Glutathione conjugates typically undergo enterohepatic circulation and can be ultimately cleaved to their cysteine S-conjugates, which can enter renal cells to produce toxicity (Anders et al., 1988; Koob and Dekant, 1991) . Since the cysteine S-conjugates DCVC and CTFC are toxic to primary cultures of human RPT cells (Chen et al., 1990) , the pathways responsible for their entry in the human RPT could play a critical role in the development of cell injury. The transport pathways involved in the uptake of cysteine conjugates by human kidney are not established, however. Indeed, marked species differences appear to exist in the handling of zwitterionic cysteine conjugates. Although in native rabbit RPT, DCVC, and CTFC are substrates for OA transport (Dantzler et al., 1995 (Dantzler et al., , 1998 Groves and Morales, 1999) in native rat RPT uptake of 35 S-DCVC is not blocked by probenecid, an inhibitor of OA transport (Zhang and Stevens, 1989) . In addition, although the anionic N-acetyl derivative of DCVC (NAC-DCVC) is a substrate for rat Oat1 (Pombrio et al., 2001) , the zwitterionic DCVC does not interact with OA transport pathways in the native rat RPT (Zhang and Stevens, 1989) . The present study is the first to document the direct interaction of nephrotoxic cysteine S-conjugates with the human renal OA transporter hOAT1. In addition, the data presented here confirm the specific interaction of cysteine S-conjugates with the rabbit ortholog of this process, rbOat1.
The cysteine S-conjugates DCVC and CTFC inhibited PAH uptake mediated by both hOAT1 and rbOat1. The apparent affinity of the OAT1s for these toxicants appeared to be lower than the affinity for the cloned transporters displayed for PAH; hOAT1 had a 20-fold lower apparent affinity and rabbit Oat1 an 8-fold lower apparent affinity for DCVC and CTFC than for PAH (Table 1 ). In contrast, the OA transport pathway in native rabbit RPT had a similar apparent affinity for DCVC, CTFC, and PAH (Table 1) . Interestingly, the affinities for DCVC and CTFC interaction with hOAT1 and rbOat1 are similar to the affinities measured in the native rabbit RPT (Table 1 ). The IC 50 of DCVC for rbOat1-mediated PAH uptake also was not very different from the measured K m of 283 M for DCVC uptake in the native rabbit RPT suspensions (Dantzler et al., 1998) . In the native tubule, however, the possibility still exists for cysteine S-conjugate interactions with multiple pathways, such as OAT2 to -4, which may contribute to the observed differences between these systems.
The affinities of both human and rabbit Oat1 for the nontoxic cysteine S-conjugate BTC were similar and approximately 10-fold higher than for DCVC and CTFC. As a more hydrophobic substrate, the increased interaction of BTC with OAT1 could be associated with a relationship between increasing hydrophobicity and increasing affinity as reported for OA transport in the native RPT (Somogyi, 1996; Ullrich et al., 1997) . The affinity of the more hydrophilic substrate PAH, however, is similar to BTC and, hence, suggests that a more complicated interaction exists between the substrate and the OAT1 transporter than can be explained simply by hydrophobicity alone. The higher affinity of the relatively hydrophilic PAH may be due to the ability to form hydrogen bonds with the transporter (Ullrich, 1997) . Although the measured affinities show variation in terms of their absolute value, the pattern of inhibition remains unaltered when comparing cysteine S-conjugate interactions with human and rabbit Oat1 with the native rabbit RPT. For hOAT1, rbOat1, and native rabbit RPT, the more hydrophobic BTC had a significantly greater affinity for inhibition of PAH transport than the more hydrophilic (compared with BTC) DCVC and CTFC, which displayed similar affinities to one another within a respective system. Although the double bond present in DCVC causes this haloalkene structure to be more hydrophobic than the haloalkane CTFC, this structural difference, in contrast to BTC, fails to have a profound effect on the inhibitory constants for inhibition of PAH uptake.
The prototypical OAT1 substrate PAH exhibited a high affinity for both hOAT1 and rbOat1. The affinity of hOAT1 for PAH was approximately 2-fold greater than for rbOat1, but the affinity of rbOat1 for PAH was also approximately 5-fold or more greater than the affinity for PAH transport measured in the native rabbit RPT (Table 1; Dantzler et al., 1995; Groves et al., 1998) . Several possible bases exist for the discrepancy in apparent K m values for PAH uptake by the native RPT and cells expressing rbOat1. First, transport of PAH in the native tubule may be influenced by parallel activity of several transporters, in addition to OAT1, that also accept PAH as a substrate (e.g., OAT2-4). PAH has been shown to be a substrate for hOAT3, with a K m of 87 M ), a value that more closely resembles the K m measured in native tubules. Second, the quantitative characteristics of OAT1 in the native tubule environment may differ markedly from those arising from expression in a cultured cell system. Finally, physical factors, including the potential influence of unstirred layers on the measurement of kinetic parameters, may complicate comparison of kinetic parameters in different experimental systems. In spite of the substantial difference in the affinity for PAH uptake noted between the rbOat1 and the native rabbit RPT, the inhibitory constants measured for BTC, DCVC, and CTFC demonstrated less variability between these two systems and suggests that OAT1 may play a significant role in cysteine S-conjugate interactions with OA transport in the native rabbit RPT.
Among the OAT transporters 1 to 4, to date only OAT1 has been shown to support a trans-stimulation of substrate transport (Sekine et al., 1998; Kusuhara et al., 1999; Cha et al., 2000) . Previous work using RPT isolated from the rabbit kidney has shown that DCVC and CTFC are capable of trans-stimulating the efflux of PAH and/or fluorescein, thereby demonstrating that these toxicants are substrates for an OA carrier (Dantzler et al., 1995 (Dantzler et al., , 1998 Groves and Morales, 1999) . Preloading hOAT1-transfected cells with the nontoxic cysteine S-conjugate BTC significantly stimulated the uptake of PAH, suggesting that cysteine S-conjugate transport is mediated by OAT1. DCVC also acts as a competitive inhibitor of hOAT1 PAH uptake, which further substantiates a role for OAT1 in the uptake of these nephrotoxicants. Transport by OAT1, however, does not preclude a role for OAT pathways 2 to 4 in cysteine S-conjugate transport. For example, the OA substrate ochratoxin A is transported by both hOAT1 and renal hOAT3 (Jung et al., 2001 ). In the native rabbit RPT, 5 mM PAH, a concentration 50-fold greater than the K m for PAH transport, only reduced the uptake and the subsequent nephrotoxicity of DCVC by approximately 70%, which also indicates that DCVC uptake in the RPT could involve both OAT1 and a different OAT pathway. Since glutathione conjugation of various halogenated hydrocarbons and transport of metabolites appears to contribute significantly to their subsequent renal pathophysiology, investigation of the transport properties of all OAT transporters will be necessary to completely understand the mechanisms involved in the renal handling of cysteine Sconjugates.
In conclusion, zwitterionic cysteine S-conjugates directly inhibited the uptake of PAH mediated by the cloned OA transporters hOAT1 and rbOat1. The affinities for inhibition and the pattern of inhibition of PAH transport produced by cysteine S-conjugate interaction with rbOat1 was similar to that reported for the native rabbit RPT. Cysteine S-conjugates also competitively inhibited and are transported by hOAT1. Thus, entry into the renal cell via this pathway may contribute to the onset of nephrotoxicity and carcinogenicity associated with these toxicants.
